Dimensional Fund Advisors
OKUR

Dimensional Fund Advisors’s OnKure Therapeutics OKUR Stock Holding History

Dimensional Fund Advisors’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,333
Closed -$22.7K – 3371
2024
Q3 		$22.7K Hold
1,333
– – ﹤0.01% 3330
2024
Q2 		$20.1K Hold
1,333
– – ﹤0.01% 3351
2024
Q1 		$22.1K Hold
1,333
– – ﹤0.01% 3362
2023
Q4 		$21.3K Sell
1,333
-3,650
-73% -$227K ﹤0.01% 3385
2023
Q3 		$379K Sell
4,983
-370
-7% -$25.2K ﹤0.01% 3098
2023
Q2 		$351K Buy
5,353
+1,651
+45% +$133K ﹤0.01% 3133
2023
Q1 		$221K Buy
3,702
+1,747
+89% +$63.3K ﹤0.01% 3185
2022
Q4 		$45 Buy
1,955
+113
+6% +$3K ﹤0.01% 3402
2022
Q3 		$62K Buy
+1,842
New +$60.5K ﹤0.01% 3381

Other funds holding OKUR

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Dimensional Fund Advisors's OKUR Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of OnKure Therapeutics (OKUR) in Q4 2024, closing a stake of 1,333 shares — an estimated $22.7K sold.

Dimensional Fund Advisors first reported a position in OKUR in Q3 2022 and held it in 9 quarters. The position peaked at $379K in Q3 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining OnKure Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,333 OnKure Therapeutics shares in Q4 2024, an estimated $22.7K.
  • Dimensional Fund Advisors first reported a position in OnKure Therapeutics in Q3 2022 and held it in 9 quarters.
  • Dimensional Fund Advisors's OnKure Therapeutics position peaked at $379K in Q3 2023.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.